Skip to content
Plus234Feed

Omatek Ventures: GMD Exit, New Acting MD and Q3 Approval

business
OriginalBy Plus234Feed Newsroom
Omatek Ventures: GMD Exit, New Acting MD and Q3 Approval

Omatek Ventures Plc (NGX: OMATEK) filed a Board Meeting outcome dated 29 October 2026, disclosing resolutions passed at its Board of Directors meeting held on 28 October 2026. The filing covers approval of the company's Q3 2026 unaudited financial statements, the exit of its Group Managing Director and the appointment of an acting replacement.

At its Board of Directors meeting held on 28 October 2026, Omatek Ventures Plc passed three resolutions, which were disclosed in a filing submitted to the exchange on 5 November 2026.

First, the Board approved the Third Quarter Unaudited Financial Statements for the period ended 30 September 2026.

Second, the Board approved the exit of Mr. Yemi Ogundipe FCA as Group Managing Director and Director of the company, effective 30 November 2026. The Board noted his role in leading the company through seven and a half years of receivership.

Third, the Board approved the appointment of Mr. Temidayo Seriki as Acting Group Managing Director. Mr. Seriki is an existing Director of the company and currently represents the estate of the late founder, Engr. Dr. Mrs. Florence Udebu Seriki FNSE, MFR, described as the largest investor in Omatek Ventures. The filing states that Mr. Seriki will oversee the completion of ongoing discussions with prospective investors in the company.

The Company Secretary, Femi David Ikotun Esq., signed the filing. Omatek Ventures is headquartered at 12 Bissau Street, Wuse Zone 6, Abuja.

Share

Get the week in one email

Top stories, NPFL results, the naira, every Friday morning. Free, one email a week.

Free · one email per week · unsubscribe anytime

Related Stories

Get Plus234Feed on messaging apps

Same headlines, delivered where you already scroll.